PLA2G7 and congestive heart failure: It has been demonstrated that Lp-PLA2 can be used as a risk stratifier for chronic heart failure with reduced left ventricular ejection fraction (Jun-Feng et al., 2023), and also a key factor in acute ischemic stroke as an independent risk factor for poor prognosis (Chang et al., 2024).